Aemetis (NASDAQ:AMTX) Price Target Raised to $3.00 at Piper Sandler
Aemetis (NASDAQ:AMTX – Get Rating) had its price objective raised by Piper Sandler from $2.00 to $3.00 in a research note published on Tuesday morning, The Fly reports. Several other research firms have also recently commented on AMTX. Stifel Nicolaus increased their target price on Aemetis from $9.00 to $9.80 in a research note on […]